Quest Diagnostics sees uptick in COVID-19 testing as Delta variant spreads
Go back to Quest Diagnostics sees uptick in COVID-19 testing as Delta variant spreads| Quest Diagnostics (NYSE: DGX) | Delayed: 227.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $227.06 | 52 Week High | $86.85 | |||
| Open | $227.06 | 52 Week Low | $59.66 | |||
| Day High | $227.06 | P/E | 42.76 | |||
| Day Low | $227.06 | EPS | $5.31 | |||
| Volume | 4 | |||||



